Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters
- PMID: 24094422
- DOI: 10.1016/j.fertnstert.2013.09.003
Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters
Abstract
Objective: To analyze how frequently and why men presenting with infertility take testosterone (T) and if negative effects of T on semen parameters are reversed following cessation.
Design: Analysis of a prospectively collected database.
Setting: Male Infertility clinic.
Patient(s): Men presenting for fertility evaluation from 2008 to 2012.
Intervention(s): None.
Main outcome measure(s): The frequency and reason for T use in the infertile male population, and semen and hormonal parameters while on T and following discontinuation.
Result(s): A total of 59/4,400 men (1.3%) reported taking T. T was prescribed by a variety of physicians, including endocrinologists (24%), general practitioners (17%), urologists (15%), gynecologists (5%), and reproductive endocrinologists (3%). Only one of the men admitted that he had obtained T from an illicit source. More than 82% of men were prescribed T for the treatment of hypogonadism, but surprisingly, 12% (7/59) were prescribed T to treat their infertility. While on T, 88.4% of men were azoospermic, but by 6 months after T cessation, 65% of the men without other known causes for azoospermia recovered spermatogenesis.
Conclusion(s): In Canada, T was not commonly used by men presenting for fertility investigation (1.3%). Close to 2/3 of infertile men using T recovered spermatogenesis within 6 months of T discontinuation.
Keywords: Testosterone; hormones; male infertility; semen; testosterone replacement therapy.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios.Fertil Steril. 2012 Jul;98(1):48-51. doi: 10.1016/j.fertnstert.2012.04.005. Epub 2012 May 11. Fertil Steril. 2012. PMID: 22579129 Clinical Trial.
-
Redefining abnormal follicle-stimulating hormone in the male infertility population.BJU Int. 2012 Aug;110(4):568-72. doi: 10.1111/j.1464-410X.2011.10783.x. Epub 2011 Dec 16. BJU Int. 2012. PMID: 22177092
-
Finasteride use in the male infertility population: effects on semen and hormone parameters.Fertil Steril. 2013 Dec;100(6):1542-6. doi: 10.1016/j.fertnstert.2013.07.2000. Epub 2013 Sep 4. Fertil Steril. 2013. PMID: 24012200
-
The treatment of hypogonadism in men of reproductive age.Fertil Steril. 2013 Mar 1;99(3):718-24. doi: 10.1016/j.fertnstert.2012.10.052. Epub 2012 Dec 7. Fertil Steril. 2013. PMID: 23219010 Review.
-
Effect of rejuvenation hormones on spermatogenesis.Fertil Steril. 2013 Jun;99(7):1814-20. doi: 10.1016/j.fertnstert.2013.04.003. Epub 2013 May 10. Fertil Steril. 2013. PMID: 23663992 Review.
Cited by
-
Age-related testosterone decline: mechanisms and intervention strategies.Reprod Biol Endocrinol. 2024 Nov 14;22(1):144. doi: 10.1186/s12958-024-01316-5. Reprod Biol Endocrinol. 2024. PMID: 39543598 Free PMC article. Review.
-
Young Adults' Understanding of Modifiable Risk Factors of Infertility.Womens Health Rep (New Rochelle). 2024 Oct 22;5(1):815-824. doi: 10.1089/whr.2024.0058. eCollection 2024. Womens Health Rep (New Rochelle). 2024. PMID: 39450156
-
Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications.Pharmaceuticals (Basel). 2024 Sep 18;17(9):1233. doi: 10.3390/ph17091233. Pharmaceuticals (Basel). 2024. PMID: 39338395 Free PMC article. Review.
-
Male Fertility as a Proxy for Health.J Clin Med. 2024 Sep 19;13(18):5559. doi: 10.3390/jcm13185559. J Clin Med. 2024. PMID: 39337044 Free PMC article. Review.
-
Oral administration of VDAC1-derived small molecule peptides increases circulating testosterone levels in male rats.Front Endocrinol (Lausanne). 2023 Jan 4;13:1003017. doi: 10.3389/fendo.2022.1003017. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686419 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
